Anavex Life Sciences Corp. (AVXL)
NASDAQ: AVXL · Real-Time Price · USD
3.375
+0.035 (1.05%)
Aug 10, 2026, 1:08 PM EDT - Market open
Anavex Life Sciences Employees
Anavex Life Sciences had 34 employees as of September 30, 2025. The number of employees decreased by 8 or -19.05% compared to the previous year.
Employees
34
Change (1Y)
-8
Growth (1Y)
-19.05%
Revenue / Employee
n/a
Profits / Employee
-$1,002,618
Market Cap
312.77M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 34 | -8 | -19.05% |
| Sep 30, 2024 | 42 | 2 | 5.00% |
| Sep 30, 2023 | 40 | 2 | 5.26% |
| Sep 30, 2022 | 38 | 13 | 52.00% |
| Sep 30, 2021 | 25 | 5 | 25.00% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Vanda Pharmaceuticals | 533 |
| Fate Therapeutics | 161 |
| Zentalis Pharmaceuticals | 106 |
| Neumora Therapeutics | 92 |
| SAB Biotherapeutics | 86 |
| Agenus | 81 |
| Immuneering | 55 |
| Surrozen | 44 |
AVXL News
- 7 days ago - Anavex Life Sciences Announces Plans to Refresh Board to Continue Overseeing Critical Progress and Stockholder Value Creation - GlobeNewsWire
- 10 days ago - Anavex Life Sciences Proxy statement: Proxy filing - Filings
- 11 days ago - Anavex Life Sciences Reports Preliminary Second Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 17 days ago - Anavex Life Sciences Proxy statement: Proxy filing - Filings
- 2 months ago - Anavex receives expected Nasdaq delinquency notification - TheFly
- 2 months ago - Anavex Life Sciences Receives Expected Nasdaq Delinquency Notification - GlobeNewsWire
- 3 months ago - Anavex delays 10Q filing - TheFly
- 3 months ago - Anavex Life Sciences names Terrie Kellmeyer interim CEO, succeeding Missling - TheFly